<DOC>
	<DOCNO>NCT01200173</DOCNO>
	<brief_summary>This multicentric , randomize , double-blind control study aim examine effect ferment dairy product contain probiotic Lactobacillus casei DN-114 001 ( Actimel® = test product ) incidence respiratory gastro-intestinal common infectious disease ( cumulate number infection intervention period : primary criterion ) child age 3-6 year , attend day care centers.Volunteers receive either 200g/day test product ( N=300 ) control product ( N=299 ) 3-months , follow 1-month follow-up .</brief_summary>
	<brief_title>Effect Consumption Fermented Milk Common Infections Children Aged 3-6 Years , Attending Day Care Centers</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Subject whose parents/legal guardian give write informed consent , Male female , age 3 6 year ( upper bound exclude ) , Attending daycare centre preschools 5 day week Moscow area , Subject find medically healthy ( particular , free respiratory GI tract symptom ) , Subject appreciate dairy product multifruit flavour . Subject whose parent read write Russian , understand inform consent study protocol . Subject allergy hypersensitivity milk proteins dairy food component ( ex : lactose , milk protein ) , know food respiratory allergy . Subject present severe evolutive chronic pathology ( Ex : cancer , tuberculosis , Crohn disease , cirrhosis , multiple sclerosis , Type I diabetes… ) past actual health condition could interfere outcome study ( Ex : HIV , Chemotherapy , malabsorption , ulcer , celiac disease , failure thrive… ) . Subject experience infectious disease last 7 day . Subject current diarrhoea constipation Subject frequently use laxative use laxative week prior participation study . Subject artificial nutrition , gastrointestinal surgery intervention require general anaesthesia last 2 month prior participation study . Subject special medicate diet ( obesity , anorexia , metabolic pathology , nutritional complementation… ) eat disorder ( anorexia , bulimia… ) . Subject currently receive , receive last month , systemic treatment topical treatment likely interfere evaluation study parameter : antibiotic , antiseptic , antifungal , corticoid , vaccine , antihistaminic molecule , noncorticoid antiinflammatory substance , immunosuppressant treatment… Subject already enrol another clinical study , currently exemption period previous study . Subject situation investigator 's opinion could interfere optimal participation present study could constitute special risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Probiotic - Lactobacillus casei DN-114 001 - dairy</keyword>
	<keyword>product - infection - child</keyword>
</DOC>